Dopamine D2 and acetylcholine α7 nicotinic receptors have subcellular distributions favoring mediation of convergent signaling in the mouse ventral tegmental area

Neuroscience

Volumn 252, Issue , 2013, Pages 126-143

  Garzon M ^a,b,c   Duffy, A M ^a,d   Chan, J ^a   Lynch, M K ^a   Mackie, K ^e   Pickel, V M ^a  

^a FEIL FAMILY BRAIN AND MIND RESEARCH INSTITUTE   (United States)

^b AUTONOMOUS UNIVERSITY OF MADRID   (Spain)

^c HOSPITAL UNIVERSITARIO LA PAZ IDIPAZ   (Spain)

^d NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^e INDIANA UNIVERSITY   (United States)

Author keywords

Addiction; Electron microscopic immunolabeling; Mesocorticolimbic; Reward; Schizophrenia

Indexed keywords

BUNGAROTOXIN RECEPTOR; DOPAMINE 2 RECEPTOR;

ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DENDRITE; GLIA; IMMUNOELECTRON MICROSCOPY; MOUSE; NERVE ENDING; NERVE FIBER; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SYNAPTIC MEMBRANE; VENTRAL TEGMENTUM;

ABC; ACETYLCHOLINE; ACH; ADDICTION; ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTORS; AVIDIN-BIOTIN COMPLEX; BOVINE SERUM ALBUMIN; BSA; D(2)R; DOPAMINE D(2) RECEPTOR; ELECTRON MICROSCOPIC IMMUNOLABELING; G-PROTEIN-COUPLED INWARDLY RECTIFYING POTASSIUM; GIRK; MESOCORTICOLIMBIC; METHYLLYCACONITINE; MLA; N-METHYL-D-ASPARTATE RECEPTOR; NAC; NACHR; NICOTINIC ACETYLCHOLINE RECEPTOR; NMDA; NUCLEUS ACCUMBENS; PB; PBS; PHOSPHATE BUFFER; PHOSPHATE-BUFFERED SALINE; REWARD; SCHIZOPHRENIA; TRIS-BUFFERED SALINE; TS; VENTRAL TEGMENTAL AREA; VTA; Α7NACHRS;

ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR; ANIMALS; DOPAMINERGIC NEURONS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL; MICROSCOPY, ELECTRON, TRANSMISSION; RECEPTORS, DOPAMINE D2; REWARD; VENTRAL TEGMENTAL AREA;

EID: 84883507171     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2013.08.008     Document Type: Article

References (153)

1. Ahn K.C., Bernier B.E., Harnett M.T., Morikawa H. IP3 receptor sensitization during in vivo amphetamine experience enhances NMDA receptor plasticity in dopamine neurons of the ventral tegmental area. J Neurosci 2010, 30:6689-6699.
2. Amantea D., Bowery N.G. Reduced inhibitory action of a GABAB receptor agonist on [3H]-dopamine release from rat ventral tegmental area in vitro after chronic nicotine administration. BMC Pharmacol 2004, 4:24.
3. Araque A., Parpura V., Sanzgiri R., Haydon P. Glutamate-dependent astrocyte modulation of synaptic transmission between cultured hippocampal neurons. Eur J Neurosci 1998, 10:2129-2142.
4. Arnaiz-Cot J., Gonzalez J., Sobrado M., Baldelli P., Carbone E., Gandia L., Garcia A., Hernandez-Guijo J. Allosteric modulation of alpha 7 nicotinic receptors selectively depolarizes hippocampal interneurons, enhancing spontaneous GABAergic transmission. Eur J Neurosci 2008, 27:1097-1110.
5. Aronin N., DiFiglia M. The subcellular localization of the G-protein Gi alpha in the basal ganglia reveals its potential role in both signal transduction and vesicle trafficking. J Neurosci 1992, 12:3435-3444.
6. Azam L., Winzer-Serhan U.H., Chen Y., Leslie F.M. Expression of neuronal nicotinic acetylcholine receptor subunit mRNAs within midbrain dopamine neurons. J Comp Neurol 2002, 444:260-274.
7. Balfour D.J. The neuronal pathways mediating the behavioral and addictive properties of nicotine. Handb Exp Pharmacol 2009, 192:209-233.
8. Baudier J., Glasser N., Gerard D. Ions binding to S100 proteins. I. Calcium- and zinc-binding properties of bovine brain S100 alpha alpha, S100a (alpha beta), and S100b (beta beta) protein: Zn2+ regulates Ca2+ binding on S100b protein. J Biol Chem 1986, 261:8192-8203.
9. Becker J., Gomes I., Ghisolfi E.S., Schush A., Ramos F.L., Ehlers J.A., Nora D.B., Lara D.R., da Costa J.C. Clozapine, but not typical antipsychotics, correct P50 suppression deficit in patients with schizophrenia. Clin Neurophysiol 2004, 115:396-401.
10. Beckstead M.J., Grandy D.K., Wickman K., Williams J.T. Vesicular dopamine release elicits an inhibitory postsynaptic current in midbrain dopamine neurons. Neuron 2004, 42:939-946.
11. Bellone C., Lüscher C. Cocaine triggered AMPA receptor redistribution is reversed in vivo by mGluR-dependent long-term depression. Nat Neurosci 2006, 9:636-641.
12. Bezzi P., Carmignoto G., Pasti L., Vesce S., Rossi D., Rizzini B., Pozzan T., Volterra A. Prostaglandins stimulate calcium-dependent glutamate release in astrocytes. Nature 1998, 391:281-285.
13. Brana C., Aubert I., Charron G., Pellevoisin C., Bloch B. Ontogeny of the striatal neurons expressing the D2 dopamine receptor in humans: an in situ hybridization and receptor-binding study. Mol Brain Res 1997, 48:389-400.
14. Calabresi P., Lacey M.G., North R.A. Nicotinic excitation of rat ventral tegmental neurones in vitro studied by intracellular recording. Br J Pharmacol 1989, 98:135-140.
15. Castagna C., Viglietti-Panzica C., Carlo Panzica G. Protein S100 immunoreactivity in glial cells and neurons of the Japanese quail brain. J Chem Neuroanat 2003, 25:195-212.
16. Centeno M., Henderson J., Pau K., Bethea C. Estradiol increases alpha7 nicotinic receptor in serotonergic dorsal raphe and noradrenergic locus coeruleus neurons of macaques. J Comp Neurol 2006, 497:489-501.
17. Chan J., Aoki C., Pickel V.M. Optimization of differential immunogold-silver and peroxidase labeling with maintenance of ultrastructure in brain sections before plastic embedding. J Neurosci Methods 1990, 33:113-127.
18. Charara A., Smith Y., Parent A. Glutamatergic inputs from the pedunculopontine nucleus to midbrain dopaminergic neurons in primates: Phaseolus vulgaris-leucoagglutinin anterograde labeling combined with postembedding glutamate and GABA immunohistochemistry. J Comp Neurol 1996, 364:254-266.
19. Charpantier E., Barneoud P., Moser P., Besnard F., Sgard F. Nicotinic acetylcholine subunit mRNA expression in dopaminergic neurons of the rat substantia nigra and ventral tegmental area. Neuroreport 1998, 9:3097-3101.
20. Collins A., Salminen O., Marks M., Whiteaker P., Grady S. The road to discovery of neuronal nicotinic cholinergic receptor subtypes. Handb Exp Pharmacol 2009, 85-112.
21. Corrigall W.A., Franklin K.B., Coen K.M., Clarke P.B. The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine. Psychopharmacology (Berl) 1992, 107:285-289.
22. Cruz H.G., Ivanova T., Lunn M.L., Stoffel M., Slesinger P.A., Lüscher C. Bi-directional effects of GABA(B) receptor agonists on the mesolimbic dopamine system. Nat Neurosci 2004, 7:153-159.
23. Descarries L., Gisiger V., Steriade M. Diffuse transmission by acetylcholine in the CNS. Prog Neurobiol 1997, 53:603-625.
24. Descarries L., Mechawar N. Ultrastructural evidence for diffuse transmission by monoamine and acetylcholine neurons of the central nervous system. Prog Brain Res 2000, 125:27-47.
25. Di Chiara G. Role of dopamine in the behavioural actions of nicotine related to addiction. Eur J Pharmacol 2000, 393:295-314.
26. Dobi A., Margolis E.B., Wang H.L., Harvey B.K., Morales M. Glutamatergic and nonglutamatergic neurons of the ventral tegmental area establish local synaptic contacts with dopaminergic and nondopaminergic neurons. J Neurosci 2010, 30:218-229.
27. Dominguez del Toro E., Juiz J., Peng X., Lindstrom J., Criado M. Immunocytochemical localization of the a7 subunit of the nicotinic acetylcholine receptor in the rat central nervous system. J Comp Neurol 1994, 349:325-342.
28. Drenan R.M., Nashmi R., Imoukhuede P., Just H., McKinney S., Lester H.A. Subcellular trafficking, pentameric assembly, and subunit stoichiometry of neuronal nicotinic acetylcholine receptors containing fluorescently labeled alpha6 and beta3 subunits. Mol Pharmacol 2008, 73:27-41.
29. Duffy A.M., Fitzgerald M.L., Chan J., Robinson D.C., Milner T.A., Mackie K., Pickel V.M. Acetylcholine α7 nicotinic and dopamine D2 receptors are targeted to many of the same postsynaptic dendrites and astrocytes in the rodent prefrontal cortex. Synapse 2011, 65:1350-1367.
30. Duffy A., Zhou P., Milner T.A., Pickel V.M. Spatial and intracellular relationships between the alpha7 nicotinic acetylcholine receptor and the vesicular acetylcholine transporter in the prefrontal cortex of rat and mouse. Neuroscience 2009, 161:1091-1103.
31. Fabian-Fine R., Skehel P., Errington M., Davies H., Sher E., Stewart M., Fine A. Ultrastructural distribution of the alpha7 nicotinic acetylcholine receptor subunit in rat hippocampus. J Neurosci 2001, 21:7993-8003.
32. Finkbeiner S. Glial calcium. Glia 1993, 9:83-104.
33. Fisher J., Dani J. Nicotinic receptors on hippocampal cultures can increase synaptic glutamate currents while decreasing the NMDA-receptor component. Neuropharmacology 2000, 39:2756-2769.
34. Free R., Hazelwood L., Cabrera D., Spalding H., Namkung Y., Rankin M., Sibley D. D1 and D2 dopamine receptor expression is regulated by direct interaction with the chaperone protein calnexin. J Biol Chem 2007, 282:21285-21300.
35. Freedman R., Coon H., Myles-Worsley M., Orr-Urtreger A., Olincy A., Davis A., Polymeropoulos M., Holik J., Hopkins J., Hoff M., Rosenthal J., Waldo M., Reimherr F., Wender P., Yaw J., Young D., Breese C., Adams C., Patterson D., Adler L., Kruglyak L., Leonard S., Byerley W. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc Natl Acad Sci U S A 1997, 94:587-592.
36. Fuxe K., Dahlstrom A., Jonsson G., Marcellino D., Guescini M., Dam M., Manger P., Agnati L. The discovery of central monoamine neurons gave volume transmission to the wired brain. Prog Neurobiol 2010, 90:82-100.
37. Gao M., Jin Y., Yang K., Zhang D., Lukas R.J., Wu J. Mechanisms involved in systemic nicotine-induced glutamatergic synaptic plasticity on dopamine neurons in the ventral tegmental area. J Neurosci 2010, 30:13814-13825.
38. Garzón M., Pickel V.M. Subcellular distribution of M2 muscarinic receptors in relation to dopaminergic neurons of the rat ventral tegmental area. J Comp Neurol 2006, 498:821-839.
39. Garzón M., Vaughan R.A., Uhl G.R., Kuhar M.J., Pickel V.M. Cholinergic axon terminals in the ventral tegmental area target a subpopulation of neurons expressing low levels of the dopamine transporter. J Comp Neurol 1999, 410:197-210.
40. Geetha T., Wooten M.W. TrkA receptor endolysosomal degradation is both ubiquitin and proteasome dependent. Traffic 2008, 9:1146-1156.
41. Geisler S., Zahm D.S. Afferents of the ventral tegmental area in the rat-anatomical substratum for integrative functions. J Comp Neurol 2005, 490:270-294.
42. Geisler S., Derst C., Veh R.W., Zahm D.S. Glutamatergic afferents of the ventral tegmental area in the rat. J Neurosci 2007, 27:5730-5743.
43. Gelman M.S., Chang W., Thomas D.Y., Bergeron J.J., Prives J.M. Role of the endoplasmic reticulum chaperone calnexin in subunit folding and assembly of nicotinic acetylcholine receptors. J Biol Chem 1995, 270:15085-15092.
44. Good C., Lupica C. Properties of distinct ventral tegmental area synapses activated via pedunculopontine or ventral tegmental area stimulation in vitro. J Physiol 2009, 587:1233-1247.
45. Goto Y., Grace A.A. The dopamine system and the pathophysiology of schizophrenia: a basic science perspective. Int Rev Neurobiol 2007, 78:41-68.
46. Gray E.G. Axosomatic and axo-dendritic synapses of the cerebral cortex: an electron microscopic study. J Anat 1959, 93:420-433.
47. Green W.N., Millar N.S. Ion-channel assembly. Trends Neurosci 1995, 18:280-287.
48. Grenhoff J., Aston-Jones G., Svensson T.H. Nicotinic effects on the firing pattern of midbrain dopamine neurons. Acta Physiol Scand 1986, 128:351-358.
49. Grillner P., Svensson T.H. Nicotine-induced excitation of midbrain dopamine neurons in vitro involves ionotropic glutamate receptor activation. Synapse 2000, 38:1-9.
50. Guillin O., Abi-Dargham A., Laruelle M. Neurobiology of dopamine in schizophrenia. Int Rev Neurobiol 2007, 78:1-39.
51. Haber S., Ryoo H., Cox C., Lu W. Subsets of midbrain dopaminergic neurons in monkeys are distinguished by different levels of mRNA for the dopamine transporter: comparison with the mRNA for the D2 receptor, tyrosine hydroxylase and calbindin immunoreactivity. J Comp Neurol 1995, 362:400-410.
52. Hara Y., Yakovleva T., Bakalkin G., Pickel V. Dopamine D1 receptors have subcellular distributions conducive to interactions with prodynorphin in the rat nucleus accumbens shell. Synapse 2006, 60:1-19.
53. Hervé D., Pickel V.M., Joh T.H., Beaudet A. Serotonin axon terminals in the ventral tegmental area of the rat: fine structure and synaptic input to dopaminergic neurons. Brain Res 1987, 435:71-83.
54. Hsu S.M., Raine L., Fanger H. The use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase technique: a comparison between ABC and unlabeled antibody (peroxidase) procedures. J Histochem Cytochem 1981, 29:577-599.
55. Hurd Y.L., Pristupa Z.B., Herman M.M., Niznik H.B., Kleinman J.E. The dopamine transporter and dopamine D2 receptor messenger RNAs are differentially expressed in limbic- and motor-related subpopulations of human mesencephalic neurons. Neuroscience 1994, 63:357-362.
56. Jin Y., Yang K., Wang H., Wu J. Exposure of nicotine to ventral tegmental area slices induces glutamatergic synaptic plasticity on dopamine neurons. Synapse 2011, 65:332-338.
57. Jones I., Wonnacott S. Precise localization of alpha7 nicotinic acetylcholine receptors on glutamatergic axon terminals in the rat ventral tegmental area. J Neurosci 2004, 24:11244-11252.
58. Johnson S.W., North R.A. Two types of neurone in the rat ventral tegmental area and their synaptic inputs. J Physiol 1992, 450:455-468.
59. Kabbani N., Woll M.P., Levenson R., Lindstrom J.M., Changeux J.P. Intracellular complexes of the beta2 subunit of the nicotinic acetylcholine receptor in brain identified by proteomics. Proc Natl Acad Sci U S A 2007, 104:20570-20575.
60. Kalivas P.W., Churchill L., Klitenick M.A. GABA and enkephalin projection from the nucleus accumbens and ventral pallidum to the ventral tegmental area. Neuroscience 1993, 57:1047-1060.
61. Kaplan AR, Doyle T, Casey E, Free RB, Sibley DR, Rubenstein M, Alvarez VA (2012) Distinct roles of dopamine D2 receptors in dorsal and ventral striatum on motor and drug-related behaviors. In: Society for Neuroscience Abstract 42nd Annual Meeting, New Orleans, LA.
62. Kearn C., Blake-Palmer K., Daniel E., Mackie K., Glass M. Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: a mechanism for receptor cross-talk?. Mol Pharmacol 2005, 67:1697-1704.
63. Keller S.H., Lindstrom J., Ellisman M., Taylor P. Adjacent basic amino acid residues recognized by the COP I complex and ubiquitination govern endoplasmic reticulum to cell surface trafficking of the nicotinic acetylcholine receptor alpha-subunit. J Biol Chem 2001, 276:18384-18391.
64. Khan Z., Koulen P., Rubinstein M., Grandy D., Goldman-Rakic P. An astroglia-linked dopamine D2-receptor action in prefrontal cortex. Proc Natl Acad Sci U S A 2001, 98:1964-1969.
65. Kim O., Ariano M., Namkung Y., Marinec P., Kim E., Han J., Sibley D. D2 dopamine receptor expression and trafficking is regulated through direct interactions with ZIP. J Neurochem 2008, 106:83-95.
66. Kitai S.T., Shepard P.D., Callaway J.C., Scroggs R. Afferent modulation of dopamine neuron firing patterns. Curr Opin Neurobiol 1999, 9:690-697.
67. Klink R., d'Exaerde de Kerchove A., Zoli M., Changeux J.P. Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei. J Neurosci 2001, 21:1452-1463.
68. Koch M., Schmid A., Schnitzler H.U. Role of nucleus accumbens dopamine D1 and D2 receptors in instrumental and Pavlovian paradigms of conditioned reward. Psychopharmacology (Berl) 2000, 152:67-73.
69. Koga E., Momiyama T. Presynaptic dopamine D2-like receptors inhibit excitatory transmission onto rat ventral tegmental dopaminergic neurones. J Physiol 2000, 523:163-173.
70. Labouèbe G., Lomazzi M., Cruz H.G., Creton C., Luján R., Li M., Yanagawa Y., Obata K., Watanabe M., Wickman K., Boyer S.B., Slesinger P.A., Lüscher C. RGS2 modulates coupling between GABAB receptors and GIRK channels in dopamine neurons of the ventral tegmental area. Nat Neurosci 2007, 10:1559-1568.
71. 2 receptors to increase potassium conductance in neurons of the rat substantia nigra zona compacta. J Physiol (Lond) 1987, 392:397-416.
72. Laviolette S.R., van der Kooy D. The motivational valence of nicotine in the rat ventral tegmental area is switched from rewarding to aversive following blockade of the a7-subunit-containing nicotinic acetylcholine receptor. Psychopharmacology 2003, 166:306-313.
73. Leiser S.C., Bowlby M.R., Comery T.A., Dunlop J. A cog in cognition: how the alpha 7 nicotinic acetylcholine receptor is geared towards improving cognitive deficits. Pharmacol Ther 2009, 122:302-311.
74. Leranth C., Pickel V.M. Electron microscopic pre-embedding double immunostaining methods. Neuroanatomical tract-tracing methods 2: Recent progress 1989, 129-172. Plenum Publishing Co, New York. L. Heimer, L. Zaborszky (Eds.).
75. Levin E., Rezvani A. Nicotinic interactions with antipsychotic drugs, models of schizophrenia and impacts on cognitive function. Biochem Pharmacol 2007, 74:1182-1191.
76. Levin E., Simon B. Nicotinic acetylcholine involvement in cognitive function in animals. Psychopharmacology (Berl) 1998, 138:217-230.
77. Levy R., Aoki C. Alpha7 nicotinic acetylcholine receptors occur at postsynaptic densities of AMPA receptor-positive and -negative excitatory synapses in rat sensory cortex. J Neurosci 2002, 22:5001-5015.
78. Li W., Doyon W.M., Dani J.A. Quantitative unit classification of ventral tegmental area neurons in vivo. J Neurophysiol 2012, 107:2808-2820.
79. Mameli-Engvall M., Evrard A., Pons S., Maskos U., Svensson T.H., Changeux J.P., Faure P. Hierarchical control of dopamine neuron-firing patterns by nicotinic receptors. Neuron 2006, 50:911-921.
80. Mansvelder H.D., McGehee D.S. Long-term potentiation of excitatory inputs to brain reward areas by nicotine. Neuron 2000, 27:349-357.
81. Mao D., Gallagher K., McGehee D.S. Nicotine potentiation of excitatory inputs to ventral tegmental area dopamine neurons. J Neurosci 2011, 31:6710-6720.
82. Mark G.P., Shabani S., Dobbs L.K., Hansen S.T. Cholinergic modulation of mesolimbic dopamine function and reward. Physiol Behav 2011, 104:76-81.
83. Markou A., Paterson N.E. The nicotinic antagonist methyllycaconitine has differential effects on nicotine self-administration and nicotine withdrawal in the rat. Nicotine Tob Res 2001, 3:361-373.
84. Martina M., Bergeron R. D1 and D4 dopaminergic receptor interplay mediates coincident G protein-independent and dependent regulation of glutamate NMDA receptors in the lateral amygdala. J Neurochem 2008, 106:2421-2435.
85. McLane K., Wu X., Lindstrom J., Conti-Tronconi B. Epitope mapping of polyclonal and monoclonal antibodies against two alpha-bungarotoxin-binding alpha subunits from neuronal nicotinic receptors. J Neuroimmunol 1992, 38:115-128.
86. Meador-Woodruff J., Mansour A., Healy D., Kuehn R., Zhou Q., Bunzow J., Akil H., Civelli O., Watson S. Comparison of the distributions of D1 and D2 dopamine receptor mRNAs in rat brain. Neuropsychopharmacology 1991, 5:231-242.
87. Mercuri N.B., Saiardi A., Bonci A., Picetti R., Calabresi P., Bernardi G., Borrelli E. Loss of autoreceptor function in dopaminergic neurons from dopamine D2 receptor deficient mice. Neuroscience 1997, 79:323-327.
88. Mereu G., Yoon K.-W.P., Boi V., Gessa G.L., Naes L., Westfall T.C. Preferential stimulation of ventral tegmental area dopaminergic neurons by nicotine. Eur J Pharmacol 1987, 141:395-399.
89. Michaeli A., Yaka R. Dopamine inhibits GABA(A) currents in ventral tegmental area dopamine neurons via activation of presynaptic G-protein coupled inwardly-rectifying potassium channels. Neuroscience 2010, 165:1159-1169.
90. Michaeli A., Yaka R. Dopamine-related drugs act presynaptically to potentiate GABA(A) receptor currents in VTA dopamine neurons. Neuropharmacology 2011, 61:234-244.
91. Millar N.S., Harkness P.C. Assembly and trafficking of nicotinic acetylcholine receptors (Review). Mol Membr Biol 2008, 25:279-292.
92. Missale C., Nash S., Robinson S., Jaber M., Caron M. Dopamine receptors: from structure to function. Physiol Rev 1998, 78:189-225.
93. Nardin P., Tramontina A.C., Quincozes-Santos A., Tortorelli L.S., Lunardi P., Klein P.R., Wartchow K.M., Bobermin L.D., Gottfried C., Elisabetsky E., Goncalves C.A. In vitro S100B secretion is reduced by apomorphine: effects of antipsychotics and antioxidants. Prog Neuropsychopharmacol Biol Psychiatry 2011, 35:1291-1296.
94. Navarrete M., Perea G., Fernandez de Sevilla D., Gómez-Gonzalo M., Núñez A., Martín E.D., Araque A. Astrocytes mediate in vivo cholinergic-induced synaptic plasticity. PLoS Biol 2012, 10(2):e1001259. 10.1371/journal.pbio.1001259.
95. Nimitvilai S., Brodie M.S. Reversal of prolonged dopamine inhibition of dopaminergic neurons of the ventral tegmental area. J Pharmacol Exp Ther 2010, 333:555-563.
96. Nirenberg M.J., Chan J., Vaughan R.A., Uhl G.R., Kuhar M.J., Pickel V.M. Immunogold localization of the dopamine transporter: an ultrastructural study of the rat ventral tegmental area. J Neurosci 1997, 17:5255-5262.
97. Oikawa H., Nakamichi N., Kambe Y., Ogura M., Yoneda Y. An increase in intracellular free calcium ions by nicotinic acetylcholine receptors in a single cultured rat cortical astrocyte. J Neurosci Res 2005, 79:535-544.
98. Olincy A., Freedman R. Nicotinic mechanisms in the treatment of psychotic disorders: a focus on the alpha7 nicotinic receptor. Handb Exp Pharmacol 2012, 211-232.
99. Olincy A., Harris J., Johnson L., Pender V., Kongs S., Allensworth D., Ellis J., Zerbe G., Leonard S., Stevens K., Stevens J., Martin L., Adler L., Soti F., Kem W., Freedman R. Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia. Arch Gen Psychiatry 2006, 63:630-638.
100. Omelchenko N., Sesack S.R. Laterodorsal tegmental projections to identified cell populations in the rat ventral tegmental area. J Comp Neurol 2005, 483:217-235.
101. Omelchenko N., Sesack S.R. Glutamate synaptic inputs to ventral tegmental area neurons in the rat derive primarily from subcortical sources. Neuroscience 2007, 146:1259-1274.
102. Omelchenko N., Sesack S.R. Ultrastructural analysis of local collaterals of rat ventral tegmental area neurons: GABA phenotype and synapses onto dopamine and GABA cells. Synapse 2009, 63:895-906.
103. Orr-Urtreger A., Göldner F.M., Saeki M., Lorenzo I., Goldberg L., De Biasi M., Dani J.A., Patrick J.W., Beaudet A.L. Mice deficient in the alpha7 neuronal nicotinic acetylcholine receptor lack alpha-bungarotoxin binding sites and hippocampal fast nicotinic currents. J Neurosci 1997, 17:9165-9171.
104. 7 nicotinic receptor antagonist, on nicotine- and cocaine-induced potentiation of brain stimulation reward. Psychopharmacology 2000, 149:388-396.
105. Parent A., Parent M., Charara A. Glutamatergic inputs to midbrain dopaminergic neurons in primates. Parkinsonism Relat Disord 1999, 5:193-201.
106. Pasti L., Volterra A., Pozzan T., Carmignoto G. Intracellular calcium oscillations in astrocytes: a highly plastic, bidirectional form of communication between neurons and astrocytes in situ. J Neurosci 1997, 17:7817-7830.
107. Patti L., Raiteri L., Grilli M., Zappettini S., Bonanno G., Marchi M. Evidence that alpha7 nicotinic receptor modulates glutamate release from mouse neocortical gliosomes. Neurochem Int 2007, 51:1-7.
108. Paxinos G., Franklin K.B.J. The mouse brain in stereotaxic coordinates 2001, Academic Press, San Diego.
109. Perea G., Araque A. Glial calcium signaling and neuron-glia communication. Cell Calcium 2005, 38:375-382.
110. Perea G., Araque A. Glia modulates synaptic transmission. Brain Res Rev 2010, 63:93-102.
111. Perea G., Navarrete M., Araque A. Tripartite synapses: astrocytes process and control synaptic information. Trends Neurosci 2009, 32:421-431.
112. Peters A., Palay S., Webster H. The fine structure of the nervous system 1991, Oxford University Press, New York.
113. Picciotto M.R., Zoli M., Rimondini R., Lena C., Marubio L.M., Pich E.M., Fuxe K., Changeux J.P. Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine. Nature 1998, 391:173-177.
114. Pickel V.M., Chan J., Kearn C., Mackie K. Targeting dopamine D2 and cannabinoid-1 (CB1) receptors in rat nucleus accumbens. J Comp Neurol 2006, 495:299-313.
115. Pickel V.M., Chan J., Nirenberg M.J. Region-specific targeting of dopamine D2-receptors and somatodendritic vesicular monoamine transporter 2 (VMAT2) within ventral tegmental area subdivisions. Synapse 2002, 45:113-124.
116. Pidoplichko V.I., DeBiasi M., Williams J.T., Dani J.A. Nicotine activates and desensitizes midbrain dopamine neurons. Nature 1997, 390:401-404.
117. Piper R.C., Katzmann D.J. Biogenesis and function of multivesicular bodies. Annu Rev Cell Dev Biol 2007, 23:519-547.
118. Prou D., Gu W.J., Le Crom S., Vincent J.D., Salamero J., Vernier P. Intracellular retention of the two isoforms of the D(2) dopamine receptor promotes endoplasmic reticulum disruption. J Cell Sci 2001, 114:3517-3527.
119. Reuss B., Unsicker K. Atypical neuroleptic drugs downregulate dopamine sensitivity in rat cortical and striatal astrocytes. Mol Cell Neurosci 2001, 18:197-209.
120. Reynolds E.S. The use of lead citrate at high pH as an electron-opaque stain in electron microscopy. J Cell Biol 1963, 17:208.
121. Rezvani K., Teng Y., De Biasi M. The ubiquitin-proteasome system regulates the stability of neuronal nicotinic acetylcholine receptors. J Mol Neurosci 2010, 40:177-184.
122. Saal D., Dong Y., Bonci A., Malenka R.C. Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons. Neuron 2003, 37:577-582.
123. Schilström B., De Villiers S., Malmerfelt A., Svensson T.H., Nomikos G.G. Nicotine-induced Fos expression in the nucleus accumbens and the medial prefrontal cortex of the rat: role of nicotinic and NMDA receptors in the ventral tegmental area. Synapse 2000, 36:314-321.
124. Schilström B., Nomikos G.G., Nisell M., Hertel P., Svensson T.H. N-methyl-d-aspartate receptor antagonism in the ventral tegmental area diminishes the systemic nicotine-induced dopamine release in the nucleus accumbens. Neuroscience 1998, 82:781-789.
125. Schilström B., Rawal N., Mameli-Engvall M., Nomikos G.G., Svensson T.H. Dual effects of nicotine on dopamine neurons mediated by different nicotinic receptor subtypes. Int J Neuropsychopharmacol 2003, 6:1-11.
126. Schoepfer R., Conroy W., Whiting P., Gore M., Lindstrom J. Brain alpha-bungarotoxin binding protein cDNAs and MAbs reveal subtypes of this branch of the ligand-gated ion channel gene superfamily. Neuron 1990, 5:35-48.
127. Schwieler L., Erhardt S. Inhibitory action of clozapine on rat ventral tegmental area dopamine neurons following increased levels of endogenous kynurenic acid. Neuropsychopharmacology 2003, 28:1770-1777.
128. Seguela P., Wadiche J., Dineley-Miller K., Dani J.A., Patrick J.W. Molecular cloning, functional properties, and distribution of rat brain-a7. A nicotinic cation channel highly permeable to calcium. J Neurosci 1993, 13:596-604.
129. Sesack S.R., Aoki C., Pickel V.M. Ultrastructural localization of D2 receptor-like immunoreactivity in midbrain dopamine neurons and their striatal targets. J Neurosci 1994, 14:88-106.
130. Severance E., Yolken R. Novel alpha7 nicotinic receptor isoforms and deficient cholinergic transcription in schizophrenia. Genes Brain Behav 2008, 7:37-45.
131. Sharma G., Vijayaraghavan S. Nicotinic cholinergic signaling in hippocampal astrocytes involves calcium-induced calcium release from intracellular stores. Proc Natl Acad Sci U S A 2001, 98:4148-4153.
132. Shen J.X., Yakel J.L. Functional α7 nicotinic ACh receptors on astrocytes in rat hippocampal CA1 slices. J Mol Neurosci 2012, 48:14-21.
133. Simard M., Nedergaard M. The neurobiology of glia in the context of water and ion homeostasis. Neuroscience 2004, 129:877-896.
134. Simosky J.K., Stevens K.E., Adler L.E., Freedman R. Clozapine improves deficient inhibitory auditory processing in DBA/2 mice, via a nicotinic cholinergic mechanism. Psychopharmacology (Berl) 2003, 165:386-396.
135. Steffensen S.C., Svingos A.L., Pickel V.M., Henriksen S.J. Electrophysiological characterization of GABAergic neurons in the ventral tegmental area. J Neurosci 1998, 18:8003-8015.
136. Stewart D.W., Vinci C., Adams C.E., Cohen A.S., Copeland A.L. Smoking topography and outcome expectancies among individuals with schizotypy. Psychiatry Res 2013, 205:205-212.
137. Stigliani S., Zappettini S., Raiteri L., Passalacqua M., Melloni E., Venturi C., Tacchetti C., Diaspro A., Usai C., Bonanno G. Glia re-sealed particles freshly prepared from adult rat brain are competent for exocytotic release of glutamate. J Neurochem 2006, 96:656-668.
138. Sun X., Zhao Y., Wolf M. Dopamine receptor stimulation modulates AMPA receptor synaptic insertion in prefrontal cortex neurons. J Neurosci 2005, 25:7342-7351.
139. Sziraki I., Sershen H., Hashim A., Lajtha A. Receptors in the ventral tegmental area mediating nicotine-induced dopamine release in the nucleus accumbens. Neurochem Res 2002, 27:253-261.
140. Thomas M.J., Malenka R.C., Bonci A. Modulation of long-term depression by dopamine in the mesolimbic system. J Neurosci 2000, 20:5581-5586.
141. Torrealba F., Müller C. Ultrastructure of glutamate and GABA immunoreactive axon terminals of the rat nucleus tractus solitarius, with a note on infralimbic cortex afferents. Brain Res 1999, 820:20-30.
142. Trantham-Davidson H., Kroner S., Seamans J.K. Dopamine modulation of prefrontal cortex interneurons occurs independently of DARPP-32. Cereb Cortex 2008, 18:951-958.
143. Tripathi A., Prensa L., Cebrián C., Mengual E. Axonal branching patterns of nucleus accumbens neurons in the rat. J Comp Neurol 2010, 518:4649-4673.
144. Turner T. Nicotine enhancement of dopamine release by a calcium-dependent increase in the size of the readily releasable pool of synaptic vesicles. J Neurosci 2004, 24:11328-11336.
145. Wanamaker C.P., Green W.N. Endoplasmic reticulum chaperones stabilize nicotinic receptor subunits and regulate receptor assembly. J Biol Chem 2007, 282:31113-31123.
146. Wang H., Cuzon V., Pickel V.M. Postnatal development of mu-opioid receptors in the rat caudate-putamen nucleus parallels asymmetric synapse formation. Neuroscience 2003, 118:695-708.
147. Wooltorton J.R., Pidoplichko V.I., Broide R.S., Dani J.A. Differential desensitization and distribution of nicotinic acetylcholine receptor subtypes in midbrain dopamine areas. J Neurosci 2003, 23:3176-3185.
148. Wu J., George A.A., Schroeder K.M., Xu L., Marxer-Miller S., Lucero L., Lukas R.J. Electrophysiological, pharmacological, and molecular evidence for a7-nicotinic acetylcholine receptors in rat midbrain dopamine neurons. J Pharmacol Exp Ther 2004, 311:80-91.
149. Wylie K.P., Rojas D.C., Tanabe J., Martin L.F., Tregellas J.R. Nicotine increases brain functional network efficiency. Neuroimage 2012, 63:73-80.
150. Xia Y., Driscoll J.R., Wilbrecht L., Margolis E.B., Fields H.L., Hjelmstad G.O. Nucleus accumbens medium spiny neurons target non-dopaminergic neurons in the ventral tegmental area. J Neurosci 2011, 31:7811-7816.
151. Yang K., Hu J., Lucero L., Liu Q., Zheng C., Zhen X., Jin G., Lukas R.J., Wu J. Distinctive nicotinic acetylcholine receptor functional phenotypes of rat ventral tegmental area dopaminergic neurons. J Physiol 2009, 587:345-361.
152. Zhang J., Berg D.K. Reversible inhibition of GABAA receptors by alpha7-containing nicotinic receptors on the vertebrate postsynaptic neurons. J Physiol 2007, 579:753-763.
153. Zhang X.Y., Chen D.C., Xiu M.H., Haile C.N., He S.C., Luo X., Zuo L., Rosenheck R., Kosten T.A., Kosten T.R. Cigarette smoking, psychopathology and cognitive function in first-episode drug-naive patients with schizophrenia: a case-control study. Psychol Med 2012, 1-10.